Generic Drugs and Biosimilars ICGB 2018 November 15-16, 2018 Berlin, Germany Biosimilars
Total Page:16
File Type:pdf, Size:1020Kb
th conferenceseries.com 14 International Conference on 14th International Conference on Generic Drugs and Generic Drugs and Biosimilars ICGB 2018 November 15-16, 2018 Berlin, Germany Biosimilars Generic Drugs, Generic Pills and Generic Medication Biologics & Biosimilars 200+ Participation Pharmacovigilance & Safety of Biosimilars B2B 10+ Biosimilars Uptake & Patient Safety Meetings Interactive Sessions Developing Biosimilars And Biobetters Protein Biotherapeutics & biosimilars 10+ Chronicles of a Biosimilar Production Facility 5+ Keynote Exhibitors Lectures Biosimilar development challenges 30+ Pharmacology and Drug Developement Plenary Lectures Global Generic Trends & Global Pharma Market Pharma Pricing & Market Access Patent Access& Intellectual property & FDA Regulations Drug Designing: Open Access Journal of Bioequivalence & Journal Of Developing Drugs Bioavailability Supporting Journals Berlin, Germany November 15-16, 2018 [email protected] Berlin, Germany Invitation Dear Attendees, We are glad to announce the 14th International Conference on Generic Drugs and Biosimilars to be held in Berlin, Germany on November 15-16, 2018 organized by Conference Series, UK in collaboration with generous support and cooperation from enthusiastic academicians and editorial Board Members. Generic Biosimilars 2018 is a specially designed cluster conference. The main theme of the conference is “A new Era in Biosimilars Industry –Biosimilars & Generics” which covers a wide range of critically important sessions. The biggest conference gathering of the global generic industry, attracting attendees from around the globe. The program agenda provides a unique forum for generic pharmaceutical executives from around the world to network and hear world-renowned experts discussing the latest insight into the international commercial, legal, and regulatory developments concerning the generic pharmaceutical sector Generic Biosimilars 2018 anticipates participants around the globe with thought provoking Keynote lectures, Workshops, Oral and Poster Presentations. The attending delegates include Editorial Board Members of related International Journals. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class professionals and scientists. The intending participants can confirm their participation by registering for the conference along with your colleagues. Life is full of give and take. Make it count in your professional life. Attend the Pharma Industry Conference to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level. Sincerely, Generic Biosimilars 2018 Organizing Committee Generic Biosimilars 2018 Conference Website: https://generic-market.pharmaceuticalconferences.com/ Berlin, Germany Welcome Message Dear Colleagues On Behalf of the Organizing Committee I personally welcome all the Pharmaceutical professionals to the Leading Pharmaceutical event 14th International Conference on Generic Drugs and Biosimilars historic Berlin, Germany on November 15-16, 2018 Generics and Biosimilars are an important driver in the market for urgently needed drugs. The path to new Generics and Biosimilars is a story of appreciation and innovation. Pharmaceutical products which have a proven demand in the market are selected as models for Generics and Biosimilars and significant innovation is required before a Generic or Biosimilar can be madeThe excellent available program to the doctors, and networking patients at and this payers. meeting in the historic city of Rome will provide new insights and opportunities for new lasting collaborations for all attendees. I’d like to add my best wishes for great success for the conference. SeeDr. You Anka soon G. in Ehrhardt Rome, Italy. Director Clinical Cytometry Bristol-Myers Squibb Co, USA Generic Biosimilars 2018 Conference Website: https://generic-market.pharmaceuticalconferences.com/ Berlin, Germany Organizing Committee @ Generic-Biosimilars 2018 Emmanuel O. Akala Pillhun Son Professor Projects Coordination Manager Howard University American Chemical Society USA USA Kurt R. Karst Christopher Tirotta Director Director Hyman, Phelps & McNamara Nicklaus Children’s Hospital USA USA Anka G. Ehrhardt Dipti Gulati Director President Bristol-Myers Squibb Co PJI Biotech USA USA Christoph Volpers George Perry Senior Patent Consultant Dean Michalski Hüttermann & Partners, University of Texas Germany USA Anna Szemik-Hojniak Sophia Zi Gu Director Professor INWES Education and Research University of New South Wales Institute Australia USA Generic Biosimilars 2018 Conference Website: https://generic-market.pharmaceuticalconferences.com/ Berlin, Germany Organizing Committee @ Generic-Biosimilars 2018 Adam Le Gresley George Schroeder Professor Executive Director Kingston University American Academy of Urgent United Kingdom Care Medicine USA Igor Klepikov Pierre A. Morgon Professor CEO Tel Aviv University MRGN Advisors, Geneva USA Switzerland Andrea Nicolini Zeeshan Ahmad Professor Professor University of Pisa De Montfort University Italy United Kingdom Kamali Chance Adnan Sabir Chief Regulatory Officer Principal Consultant & Founder BioSciencesCorp Pharma Consulting Services USA USA Dieter Heber Professor University of Kiel Germany Generic Biosimilars 2018 Conference Website: https://generic-market.pharmaceuticalconferences.com/ Berlin, Germany Previous Speakers @ Generic-Biosimilars 2017 Raymond A Huml Andreu Soldevila Volker Schellenberger Quintiles, USA CEO LeanBioPro, Spain Amunix Operating Inc., USA Alan L. Epstein Nigel J Rulewski Sarfaraz K. Niazi USC Keck School of Medicine Quintiles, Inc, USA TheraProteins, USA USA James Harris Christoph Volpers Upendra Nagaich Healthcare Economics LLC, USA Senior Patent Consultant at Amity Institute of Pharmacy, India Michalski & Hüttermann, Germany Gene M. Ransom, III Ronald A Rader University of Maryland and Biotechnology Information Wolfgang A. Rehmann University of Baltimore School of Institute, USA Taylor Wessing, Germany Law, USA András Guttman Gordon T. Bolger University of Pannonia,Hungary Marcus Mreyen Nucro-Technics, Canada SCIEX, USA Protagen Protein Services GmbH Germany Sumant Chaubey Min Zhang Adetunji Olawale Bills Biotech, India Fujifilm Diosynth Biotechnologies Osun State Polytechnic, Nigeria USA Tom Carver Angela Furlanetto Wragge Lawrence Graham & Co Fiona M Greer Dimock Stratton LLP, Canada UK SGS Life Sciences, Switzerland Generic Biosimilars 2018 Conference Website: https://generic-market.pharmaceuticalconferences.com/ Berlin, Germany Previous Speakers @ Generic-Biosimilars 2017 Afshin Safavi Candida Fratazzi Laszlo Endrenyi BioAgilytix , USA BBCR Consulting, USA University of Toronto, Canada Mariana Babayeva Michael G Tovey Krishna Menon Touro College Of Pharmacy, USA INSERM , France USA Andy Upsall Christina Vessely BioOutsource, UK Daniel Galbraith Biologics Consulting , USA BioOutsource Ltd, UK Samantha Little Siddhartha Roy Ruideger Janwosky Covance Laboratories Ltd, UK CSIR - Indian Institute of Chemical Cinfa Biotech GmbH, Germany Biology, India Kamali Chance Christelle Dagoneau Quintiles Inc., USA Noelle Sunstrom Catalent Biologics, USA Neuclone PTY LTD, Australia Mario DiPaola Aparna Kasinath Blue Stream Laboratories, USA Dipti Gulati Syngene International , India PJI Biotech, USA Francesco Marchesi Denise M Kettelberger Regina Elena National Cancer Alexander Pitters Sunstein Kann Murphy & Timbers Institute , Italy Kaiser Optical Systems, France LLP Generic Biosimilars 2018 Conference Website: https://generic-market.pharmaceuticalconferences.com/ Berlin, Germany Glimpses @ Generic Biosimilars 2017 Generic Biosimilars 2018 Conference Website: https://generic-market.pharmaceuticalconferences.com/ Berlin, Germany Glimpses @ Generic Biosimilars 2017 Generic Biosimilars 2018 Conference Website: https://generic-market.pharmaceuticalconferences.com/ Berlin, Germany Speaker Representations @ Generic Biosimilars 2017 Supporters Generic Biosimilars 2018 Conference Website: https://generic-market.pharmaceuticalconferences.com/ Berlin, Germany Testimonials Alistair Coates, Oviya MedSafe, UK “Very well arranged Generic Biosimilars 2017, nice experience for me as I got to meet people from a variety of backgrounds like industries and academia. Various topics are being discussed. It is very useful to someone who wants to learn more about biologics and biosimilars. Great experience at Rome. I congratulate the organizing team for a very well arranged conference”. Andreu Soldevila, LeanBioPro, Spain “Generic Biosimilars 2017 is an excellent forum to exchange your ideas & views, get new information and interact with different people from industries and academia. This conference has a great value for the people participants. I hope conferenceseries will arrange for similar conferences in future as well.” Andras Guttman, University of Pannonia, Hungary SCIEX, USA “I found Generic Biosimilars 2017 very impactful. We have very good keynote speakers each day and met a lot of speakers that basically talk about their background and have a very good size of audience with free flow of information. The best thing is we were able to use the opportunity to network after the meeting. So if you haven’t yet come to the Generic Biosimilars conference, I would recommend attending the next one as it is very impactful”. Christina Vessely, Biologics Consulting, USA “Generic Biosimilars 2017 has been an activity packed 2